Baxter International | BAX - Market Capitalization

Stock Price
17.40
Daily Change
-0.61 -3.39%
Monthly
-16.10%
Yearly
-49.70%
Q1 Forecast
16.87

Baxter International reported $8.97B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
AngioDynamics USD 278M 102M Jun/2025
AtriCure USD 1.97B 215M Dec/2025
Avanos Medical USD 648M 127M Mar/2026
Baxter International USD 9.82B 1.87B Dec/2025
Becton, Dickinson and Co. USD 55.29B 1.64B Dec/2025
Boston Scientific USD 141.35B 3.31B Dec/2025
Cooper Companies USD 14.7B 1.24B Mar/2026
Dexcom USD 25.88B 503M Dec/2025
Edwards Lifesciences USD 49.47B 3.81B Dec/2025
Fresenius EUR 28.24B 653.36M Mar/2026
Globus Medical USD 12.64B 954M Mar/2026
Halozyme Therapeutics USD 7.91B 664M Dec/2025
ICU Medical USD 3.52B 561M Dec/2025
Insulet USD 20B 1.74B Dec/2025
Integra LifeSciences USD 967M 150M Dec/2025
Intuitive Surgical USD 200.77B 40.45B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Laboratory Of America USD 20.8B 3.03B Dec/2025
Masimo USD 9.28B 2.44B Mar/2026
Merit Medical Systems USD 5.23B 297M Dec/2025
Quest Diagnostics USD 19.3B 2.01B Dec/2025
Smith & Nephew USD 3.97B 9.35B Mar/2026
Stryker USD 134.41B 6.92B Dec/2025
Tandem Diabetes Care USD 1.49B 670M Dec/2025
Teleflex USD 5.39B 91M Dec/2025
Zimmer Biomet Holdings USD 17.82B 1.69B Dec/2025